191 related articles for article (PubMed ID: 22279661)
1. [Interaction between the single-nucleotide polymorphism of DNA repair gene hOGG1 and HBV infection and its susceptibility to hepatocellular carcinoma].
Ji L; Zeng X; Li L; Qiu X; Chen S; Yu H
Wei Sheng Yan Jiu; 2011 Nov; 40(6):705-8. PubMed ID: 22279661
[TBL] [Abstract][Full Text] [Related]
2. Genetic polymorphisms of CYP2E1 and DNA repair genes HOGG1 and XRCC1: association with hepatitis B related advanced liver disease and cancer.
Bose S; Tripathi DM; Sukriti ; Sakhuja P; Kazim SN; Sarin SK
Gene; 2013 May; 519(2):231-7. PubMed ID: 23454624
[TBL] [Abstract][Full Text] [Related]
3. hOGG1 Ser326Cys and XRCC1 Arg399Gln polymorphisms associated with chronic obstructive pulmonary disease.
Yang SF; Xu YJ; Xie JG; Zhang ZX
Chin Med J (Engl); 2009 Apr; 122(8):960-6. PubMed ID: 19493423
[TBL] [Abstract][Full Text] [Related]
4. The hOGG1 Ser326Cys polymorphism and breast cancer risk: a meta-analysis.
Yuan W; Xu L; Feng Y; Yang Y; Chen W; Wang J; Pang D; Li D
Breast Cancer Res Treat; 2010 Aug; 122(3):835-42. PubMed ID: 20058067
[TBL] [Abstract][Full Text] [Related]
5. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma.
Chen CC; Yang SY; Liu CJ; Lin CL; Liaw YF; Lin SM; Lee SD; Chen PJ; Chen CJ; Yu MW
Int J Epidemiol; 2005 Dec; 34(6):1310-8. PubMed ID: 16172101
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of base-excision repair genes hOGG1 326cys and XRCC1 280His increase hepatocellular carcinoma risk.
Yuan T; Wei J; Luo J; Liu M; Deng S; Chen P
Dig Dis Sci; 2012 Sep; 57(9):2451-7. PubMed ID: 22565339
[TBL] [Abstract][Full Text] [Related]
7. Association of HLA-DRB1*13 and TNF-alpha gene polymorphisms with clearance of chronic hepatitis B infection and risk of hepatocellular carcinoma in Thai population.
Kummee P; Tangkijvanich P; Poovorawan Y; Hirankarn N
J Viral Hepat; 2007 Dec; 14(12):841-8. PubMed ID: 18070287
[TBL] [Abstract][Full Text] [Related]
8. Association of APE1 and hOGG1 polymorphisms with colorectal cancer risk in a Turkish population.
Canbay E; Cakmakoglu B; Zeybek U; Sozen S; Cacina C; Gulluoglu M; Balik E; Bulut T; Yamaner S; Bugra D
Curr Med Res Opin; 2011 Jul; 27(7):1295-302. PubMed ID: 21561390
[TBL] [Abstract][Full Text] [Related]
9. No association between hOGG1 Ser326Cys polymorphism and hepatocellular carcinoma.
Zhen-Bo T; An-Lin F; Ling L; Su-Fang Z
Hepatogastroenterology; 2013; 60(125):1101-4. PubMed ID: 23186590
[TBL] [Abstract][Full Text] [Related]
10. hOGG1 Ser326Cys polymorphism and risk of childhood acute lymphoblastic leukemia in a Chinese population.
Li Q; Huang L; Rong L; Xue Y; Lu Q; Rui Y; Li J; Tong N; Wang M; Zhang Z; Fang Y
Cancer Sci; 2011 Jun; 102(6):1123-7. PubMed ID: 21401806
[TBL] [Abstract][Full Text] [Related]
11. [Relationship between genetic polymorphism of promoter region let-7 and genetic susceptibility to hepatocellular carcinoma].
Huang F; Hu LM; Liu JB; Zhang YX; Hu ZB
Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Dec; 45(12):1093-8. PubMed ID: 22336344
[TBL] [Abstract][Full Text] [Related]
12. [Relationship between IL6 -572G/C polymorphism and hepatocellular carcinoma in men].
Liu S; Qiu XQ; Zeng XY; Bai H; Bei CH; Yang Y
Zhonghua Gan Zang Bing Za Zhi; 2012 Jun; 20(6):463-7. PubMed ID: 23044206
[TBL] [Abstract][Full Text] [Related]
13. hOGG1 Ser326Cys polymorphism and susceptibility to gallbladder cancer in a Chinese population.
Jiao X; Huang J; Wu S; Lv M; Hu Y; Jianfu ; Su X; Luo C; Ce B
Int J Cancer; 2007 Aug; 121(3):501-5. PubMed ID: 17417784
[TBL] [Abstract][Full Text] [Related]
14. [Association of XPC and XPG polymorphisms with the risk of hepatocellular carcinoma].
Li LM; Zeng XY; Ji L; Fan XJ; Li YQ; Hu XH; Qiu XQ; Yu HP
Zhonghua Gan Zang Bing Za Zhi; 2010 Apr; 18(4):271-5. PubMed ID: 20460046
[TBL] [Abstract][Full Text] [Related]
15. hOGG1 Ser326Cys polymorphism and lung cancer susceptibility.
Sugimura H; Kohno T; Wakai K; Nagura K; Genka K; Igarashi H; Morris BJ; Baba S; Ohno Y; Gao C; Li Z; Wang J; Takezaki T; Tajima K; Varga T; Sawaguchi T; Lum JK; Martinson JJ; Tsugane S; Iwamasa T; Shinmura K; Yokota J
Cancer Epidemiol Biomarkers Prev; 1999 Aug; 8(8):669-74. PubMed ID: 10744126
[TBL] [Abstract][Full Text] [Related]
16. UDP-glucuronosyltransferase 1A7 genetic polymorphisms are associated with hepatocellular carcinoma risk and onset age.
Tseng CS; Tang KS; Lo HW; Ker CG; Teng HC; Huang CS
Am J Gastroenterol; 2005 Aug; 100(8):1758-63. PubMed ID: 16086712
[TBL] [Abstract][Full Text] [Related]
17. A p53 polymorphism modifies the risk of hepatocellular carcinoma among non-carriers but not carriers of chronic hepatitis B virus infection.
Zhu ZZ; Cong WM; Liu SF; Xian ZH; Wu WQ; Wu MC; Gao B; Hou LF; Zhu GS
Cancer Lett; 2005 Nov; 229(1):77-83. PubMed ID: 15979781
[TBL] [Abstract][Full Text] [Related]
18. Rapid detection of single nucleotide polymorphisms related with lung cancer susceptibility of Chinese population.
Liang G; Pu Y; Yin L
Cancer Lett; 2005 Jun; 223(2):265-74. PubMed ID: 15896461
[TBL] [Abstract][Full Text] [Related]
19. Association of XRCC1, XRCC3, and XPD genetic polymorphism with an increased risk of hepatocellular carcinoma because of the hepatitis B and C virus.
Gulnaz A; Sayyed AH; Amin F; Khan Au; Aslam MA; Shaikh RS; Ali M
Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):166-79. PubMed ID: 23044807
[TBL] [Abstract][Full Text] [Related]
20. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection.
Qi P; Dou TH; Geng L; Zhou FG; Gu X; Wang H; Gao CF
Hum Immunol; 2010 Jun; 71(6):621-6. PubMed ID: 20188135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
